Stability is a critical factor in drug formulation, with implications for product quality, lifecycle management, and ...
China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the ...
Real-time ¹⁹F NMR enables faster, more efficient pharmaceutical synthesis by improving reaction monitoring, scalability, and ...
Functional packaging materials are increasingly designed to actively protect drug products, integrating moisture and impurity ...
For decades, discovery has relied on "brute force" mass-screening – testing thousands of random compounds hoping one will ...
After J.P. Morgan, biotech’s bold promises meet real-world challenges. In 2026, success starts with a CDMO partner who ...
The startup has partnered with Eli Lilly and enjoys the backing of some of Silicon Valley's most influential VCs.
The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...
An FDA draft guidance nixing the requirement for biosimilar manufacturers to conduct comparative efficacy studies may prove ...
Thermo Fisher Scientific is acquiring Clario for roughly $8.9 billion, a major move to boost its clinical research services.
In just three months, Phlow and Enveda generated and analyzed nearly 20,000 unique reactions, creating one of the largest high-quality datasets of its kind. The resulting uniform dataset is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback